Zonolite High Temperature Cement / Versakote / Zonolite Insulating Cement

Manufacturer: W.R. Grace & Co. Product Category: Refractory / Insulating Cement Years Produced: 1955–1975 Asbestos Type: Chrysotile Legal Tier: Trust Fund Available — W.R. Grace & Co. Asbestos PI Trust

Product Description

Zonolite High Temperature Cement, marketed under various designations including Versakote and Zonolite Insulating Cement, was a line of refractory insulating products manufactured and sold by W.R. Grace & Co. between approximately 1955 and 1975. These products were designed for use in high-heat industrial environments where conventional insulation materials could not withstand sustained thermal stress. They were formulated as cementitious compounds that could be mixed, applied, and cured to form rigid or semi-rigid insulating surfaces around boilers, furnaces, kilns, pipes, and other high-temperature equipment.

W.R. Grace marketed the Zonolite product family broadly across industrial sectors throughout the mid-twentieth century. The Zonolite brand name was applied to a range of vermiculite-based products, and several formulations in the refractory cement line incorporated asbestos fiber as a functional component. Versakote, one of the product designations within this line, was similarly applied in industrial settings requiring durable, heat-resistant coatings and insulating cements. These materials were distributed to industrial facilities, manufacturing plants, and construction projects throughout the United States during the decades of peak production.

Asbestos Content

Zonolite High Temperature Cement, Versakote, and Zonolite Insulating Cement contained chrysotile asbestos as a deliberate ingredient in their formulations. Chrysotile, sometimes referred to as white asbestos, is a serpentine-form asbestos mineral that was widely used in industrial products throughout the twentieth century for its heat resistance, tensile strength, and binding properties. In refractory cement applications, chrysotile fibers helped reinforce the cured matrix, improved resistance to thermal cracking, and extended the durability of insulating coatings under extreme temperature cycling.

Documentation associated with W.R. Grace’s asbestos personal injury trust fund proceedings confirms the presence of asbestos in this product line and identifies these products as compensable under the trust’s claims process. W.R. Grace’s broader corporate history with asbestos-containing products is extensively documented through the company’s Chapter 11 bankruptcy proceedings, which were initiated in 2001 and resulted in the establishment of the W.R. Grace & Co. Asbestos PI Trust as part of a confirmed reorganization plan.

How Workers Were Exposed

Workers in industrial environments who handled, mixed, applied, or worked in proximity to Zonolite High Temperature Cement and related products were at risk of inhaling airborne chrysotile asbestos fibers. The nature of refractory cement work created multiple pathways for fiber release and inhalation.

Mixing and preparation represented one significant exposure point. These products were often supplied as dry powder or granular compounds that required on-site mixing with water before application. Dry mixing operations generated substantial quantities of airborne dust, which could contain respirable asbestos fibers. Workers handling bags or containers of unmixed product were exposed during pouring, stirring, and blending activities.

Application and finishing created additional exposure. Workers who troweled, sprayed, or otherwise applied insulating cement to boiler surfaces, pipe systems, furnace walls, or duct assemblies worked directly with materials releasing fibers during the application process. Smoothing and finishing operations involving agitation of the wet or partially cured material also disturbed asbestos-containing compounds.

Maintenance and repair work on equipment previously insulated with these products presented ongoing exposure risks. When existing insulating cement was chipped away, cut, abraded, or replaced during routine maintenance shutdowns or facility upgrades, the cured material was mechanically disrupted and released previously bound fibers into the work environment. Maintenance personnel, pipefitters, boilermakers, and industrial laborers working in these environments could be exposed during such activities even years or decades after initial installation.

Bystander exposure was also documented in industrial settings. Workers in adjacent areas of plants and facilities where Zonolite refractory cements were being mixed or applied could inhale airborne fibers without directly handling the product themselves. Poor ventilation, common in many mid-century industrial facilities, allowed fiber concentrations to build and disperse broadly throughout work areas.

The period of peak production and use — 1955 through 1975 — predates enforceable federal asbestos exposure standards established under OSHA regulations. During this time, workers in industrial environments routinely handled asbestos-containing materials without respiratory protection, engineering controls, or material safety warnings, significantly increasing cumulative exposure levels.

Individuals who were exposed to Zonolite High Temperature Cement, Versakote, or Zonolite Insulating Cement manufactured by W.R. Grace & Co. and who subsequently developed asbestos-related diseases may be eligible to file a claim with the W.R. Grace & Co. Asbestos PI Trust.

The trust was established as part of W.R. Grace’s reorganization under Chapter 11 of the United States Bankruptcy Code. The reorganization plan, confirmed by the U.S. Bankruptcy Court, directed the creation of a dedicated asbestos personal injury trust to process and pay claims from individuals harmed by W.R. Grace asbestos-containing products. The trust operates under a Trust Distribution Procedure (TDP) that defines eligible disease categories, exposure requirements, and compensation levels.

Eligible disease categories under the W.R. Grace Asbestos PI Trust’s TDP typically include:

  • Mesothelioma — a malignant cancer of the pleural or peritoneal lining causally associated with asbestos exposure
  • Lung Cancer — primary lung malignancy in claimants with documented asbestos exposure and qualifying exposure history
  • Other Cancers — certain asbestos-associated malignancies as defined in the TDP
  • Asbestosis and Severe Asbestosis — fibrotic lung disease confirmed by qualifying pulmonary function and radiographic findings
  • Other Asbestos-Related Conditions — pleural disease and related non-malignant conditions meeting defined diagnostic criteria

To pursue a claim, claimants or their legal representatives must demonstrate a qualifying diagnosis, document occupational or environmental exposure to a covered W.R. Grace product such as Zonolite High Temperature Cement or Versakote, and satisfy the exposure criteria set forth in the TDP. Medical records, employment records, union documentation, co-worker testimony, and product identification evidence are commonly used to support claims.

Individuals who believe they were exposed to these products should consult with an attorney experienced in asbestos trust fund claims. Trust claims and any parallel civil litigation options are subject to statutes of limitations that vary by state and disease type, making timely consultation important.

This article is provided for informational and reference purposes. It is based on documented product history, trust fund records, and publicly available litigation and regulatory information. It does not constitute legal advice. Individuals seeking compensation for asbestos-related illness should consult a qualified attorney.